P53 is the single most frequently altered gene in human cancers and is present in approximately 50% of all invasive tumors [14]. P53 mutation predicted resistance to chemotherapy in diffuse large B-cell lymphoma, esophageal cancer, and oropharyngeal cancers [15]. Here, TP53 is linked to diffuse large B-cell lymphoma.